Evaluation of spironolactone plus hydrochlorothiazide in reducing proteinuria in type 2 diabetic nephropathy.
about
Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic NephropathyCorrelation of secreted protein acidic and rich in cysteine with diabetic nephropathy.Effect of vitamin D on proteinuria in type 2 diabetic patients.Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathyA systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis.
P2860
Evaluation of spironolactone plus hydrochlorothiazide in reducing proteinuria in type 2 diabetic nephropathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Evaluation of spironolactone p ...... n type 2 diabetic nephropathy.
@en
Evaluation of spironolactone p ...... n type 2 diabetic nephropathy.
@nl
type
label
Evaluation of spironolactone p ...... n type 2 diabetic nephropathy.
@en
Evaluation of spironolactone p ...... n type 2 diabetic nephropathy.
@nl
prefLabel
Evaluation of spironolactone p ...... n type 2 diabetic nephropathy.
@en
Evaluation of spironolactone p ...... n type 2 diabetic nephropathy.
@nl
P2860
P356
P1476
Evaluation of spironolactone p ...... in type 2 diabetic nephropathy
@en
P2093
Mohammad Karami Horestani
Mohammad Saeed Behradmanesh
P2860
P304
P356
10.1177/1470320313481485
P577
2013-03-13T00:00:00Z